NORDH — Nordhealth AS Income Statement
0.000.00%
Last trade - 00:00
- NOK2.67bn
- NOK2.41bn
- €36.83m
- 65
- 13
- 87
- 56
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | Interim Report | ARS | ARS | ARS |
Standards: | — | NAS | NAS | NAS |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 12.7 | 20.3 | 31.1 | 36.8 |
Cost of Revenue | ||||
Gross Profit | 10.9 | 16.7 | 26.3 | 31.7 |
Selling / General / Administrative Expenses | ||||
Depreciation and Amortization | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 10.7 | 24.8 | 45.7 | 48.2 |
Operating Profit | 1.98 | -4.46 | -14.7 | -11.4 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | 2 | -4.65 | -14.1 | -10.8 |
Provision for Income Taxes | ||||
Net Income After Taxes | 1.93 | -4.73 | -14.3 | -11.1 |
Net Income Before Extraordinary Items | ||||
Net Income | 1.93 | -4.73 | -14.3 | -11.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | 1.93 | -4.73 | -14.3 | -11.1 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | 0.03 | -0.022 | -0.093 | -0.055 |
Dividends per Share |